0001752724-20-272879.txt : 20201228 0001752724-20-272879.hdr.sgml : 20201228 20201228143314 ACCESSION NUMBER: 0001752724-20-272879 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201031 FILED AS OF DATE: 20201228 PERIOD START: 20210731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock ETF Trust CENTRAL INDEX KEY: 0001761055 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-23402 FILM NUMBER: 201417944 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: 8004417762 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 0001761055 S000069260 BlackRock Future Health ETF C000221226 BlackRock Future Health ETF NPORT-P 1 primary_doc.xml NPORT-P false 0001761055 XXXXXXXX S000069260 C000221226 BlackRock ETF Trust 811-23402 0001761055 5493007WBHAKV9JVS642 100 BELLEVUE PARKWAY WILMINGTON 19809 800-441-7762 BlackRock Future Health ETF S000069260 549300QSHQQEGUGOU050 2021-07-31 2020-10-31 N 6089751.59 58452.03 6031299.56 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 4056.52000000 N Akeso Inc 254900ECWYGR3QW5GF30 Akeso Inc 000000000 6000.00000000 NS 18801.14000000 0.311726184596 Long EC CORP KY N 1 N N N Argenx SE 7245009C5FZE6G9ODQ71 Argenx SE 04016X101 282.00000000 NS USD 69972.66000000 1.160158922698 Long EC CORP NL N 1 N N N Charles River Laboratories International Inc 549300BSQ0R4UZ5KX287 Charles River Laboratories International Inc 159864107 216.00000000 NS USD 49183.20000000 0.815466045264 Long EC CORP US N 1 N N N Kodiak Sciences Inc 254900IXI5NI8C9OQE24 Kodiak Sciences Inc 50015M109 420.00000000 NS USD 38140.20000000 0.632371176735 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 205.00000000 NS USD 42713.80000000 0.708202263460 Long EC CORP US N 1 N N N Astellas Pharma Inc 529900IB708DY2HBBB35 Astellas Pharma Inc 000000000 2400.00000000 NS 32944.33000000 0.546222744737 Long EC CORP JP N 1 N N N Genetron Holdings Ltd N/A Genetron Holdings Ltd 37186H100 2280.00000000 NS USD 23028.00000000 0.381808261568 Long EC CORP KY N 1 N N N ZYMEWORKS INC 894500AHOYAGYLYZJL67 Zymeworks Inc 98985W102 594.00000000 NS USD 23237.28000000 0.385278160516 Long EC CORP CA N 1 N N N TCR2 Therapeutics Inc 5493007TR1ORJAZ8YK34 TCR2 Therapeutics Inc 87808K106 534.00000000 NS USD 10503.78000000 0.174154506761 Long EC CORP US N 1 N N N Hansoh Pharmaceutical Group Co Ltd 254900Q6MR00EBXTPF42 Hansoh Pharmaceutical Group Co Ltd 000000000 24000.00000000 NS 106926.63000000 1.772862198872 Long EC CORP KY N 1 N N N American Well Corp N/A American Well Corp 03044L105 1566.00000000 NS USD 40418.46000000 0.670145125406 Long EC CORP US N 1 N N N Centene Corp 549300Z7JJ4TQSQGT333 Centene Corp 15135B101 846.00000000 NS USD 49998.60000000 0.828985519664 Long EC CORP US N 1 N N N Biohaven Pharmaceutical Holding Co Ltd 5299007STZTNN32O9920 Biohaven Pharmaceutical Holding Co Ltd 000000000 205.00000000 NS USD 15879.30000000 0.263281567132 Long EC CORP VG N 1 N N N BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES 5493008LW2651I1QB503 BlackRock Cash Funds: Treasury, SL Agency Shares 066922477 140000.00000000 NS USD 140000.00000000 2.321224449345 Long STIV RF US N 1 N N N Agios Pharmaceuticals Inc 529900ONJHY8EOGYT555 Agios Pharmaceuticals Inc 00847X104 1038.00000000 NS USD 41592.66000000 0.689613566466 Long EC CORP US N 1 N N N Straumann Holding AG 50670046ML5FVIM60Z37 Straumann Holding AG 000000000 78.00000000 NS 81357.26000000 1.348917578884 Long EC CORP CH N 1 N N N PPD Inc N/A PPD Inc 69355F102 3996.00000000 NS USD 131388.48000000 2.178443943845 Long EC CORP US N 1 N N N Teleflex Inc UUL85LWXB4NGSWWXIQ25 Teleflex Inc 879369106 336.00000000 NS USD 106925.28000000 1.772839815636 Long EC CORP US N 1 N N N Zentalis Pharmaceuticals Inc N/A Zentalis Pharmaceuticals Inc 98943L107 534.00000000 NS USD 21141.06000000 0.350522466836 Long EC CORP US N 1 N N N Taysha Gene Therapies Inc N/A Taysha Gene Therapies Inc 877619106 420.00000000 NS USD 8736.00000000 0.144844405639 Long EC CORP US N 1 N N N Arrowhead Pharmaceuticals Inc 549300O3CSB8T7OZ3D66 Arrowhead Pharmaceuticals Inc 04280A100 198.00000000 NS USD 11345.40000000 0.188108713340 Long EC CORP US N 1 N N N Cytokinetics Inc 549300BE5DY1HW7IHA64 Cytokinetics Inc 23282W605 604.00000000 NS USD 9283.48000000 0.153921719650 Long EC CORP US N 1 N N N ALX Oncology Holdings Inc N/A ALX Oncology Holdings Inc 00166B105 672.00000000 NS USD 26550.72000000 0.440215574369 Long EC CORP US N 1 N N N Akouos Inc N/A Akouos Inc 00973J101 655.00000000 NS USD 12713.55000000 0.210792879271 Long EC CORP US N 1 N N N Kadmon Holdings Inc 549300BBVICD23L50606 Kadmon Holdings Inc 48283N106 3420.00000000 NS USD 11628.00000000 0.192794270692 Long EC CORP US N 1 N N N RAPT Therapeutics Inc 549300MB473BIU78ES48 RAPT Therapeutics Inc 75382E109 444.00000000 NS USD 12760.56000000 0.211572313281 Long EC CORP US N 1 N N N Mirati Therapeutics Inc 529900GYRW59IDQV6N54 Mirati Therapeutics Inc 60468T105 213.00000000 NS USD 46250.82000000 0.766846672759 Long EC CORP US N 1 N N N GoHealth Inc N/A GoHealth Inc 38046W105 281.00000000 NS USD 2911.16000000 0.048267541199 Long EC CORP US N 1 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 84.00000000 NS USD 24586.80000000 0.407653437794 Long EC CORP US N 1 N N N Immunovant Inc N/A Immunovant Inc 45258J102 600.00000000 NS USD 26172.00000000 0.433936330630 Long EC CORP US N 1 N N N Alcon Inc 549300LDT5AP8S0NBM78 Alcon Inc 000000000 1830.00000000 NS USD 104017.20000000 1.724623341374 Long EC CORP CH N 1 N N N Demant A/S 213800RM6L9LN78BVA56 Demant A/S 000000000 1644.00000000 NS 51778.11000000 0.858490106235 Long EC CORP DK N 1 N N N C4 Therapeutics Inc N/A C4 Therapeutics Inc 12529R107 797.00000000 NS USD 19725.75000000 0.327056379869 Long EC CORP US N 1 N N N Seres Therapeutics Inc 549300GMXBE5NUWISF13 Seres Therapeutics Inc 81750R102 876.00000000 NS USD 24431.64000000 0.405080857897 Long EC CORP US N 1 N N N Cardiovascular Systems Inc 549300NUBWKJMNMQ3287 Cardiovascular Systems Inc 141619106 396.00000000 NS USD 14117.40000000 0.234068957437 Long EC CORP US N 1 N N N Chugai Pharmaceutical Co Ltd 529900T9LAII161DCN95 Chugai Pharmaceutical Co Ltd 000000000 700.00000000 NS 26924.62000000 0.446414901666 Long EC CORP JP N 1 N N N ConvaTec Group PLC 213800LS272L4FIDOH92 ConvaTec Group PLC 000000000 10962.00000000 NS 25612.18000000 0.424654417264 Long EC CORP GB N 1 N N N Kymera Therapeutics Inc N/A Kymera Therapeutics Inc 501575104 636.00000000 NS USD 22889.64000000 0.379514228605 Long EC CORP US N 1 N N N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics Inc 88025U109 114.00000000 NS USD 15606.60000000 0.258760153508 Long EC CORP US N 1 N N N NuVasive Inc 549300C5ZB4NZ6TWM881 NuVasive Inc 670704105 324.00000000 NS USD 14395.32000000 0.238676919572 Long EC CORP US N 1 N N N Vir Biotechnology Inc N/A Vir Biotechnology Inc 92764N102 312.00000000 NS USD 9809.28000000 0.162639575474 Long EC CORP US N 1 N N N Silk Road Medical Inc 549300VL8KC0ZPDQHE14 Silk Road Medical Inc 82710M100 708.00000000 NS USD 42904.80000000 0.711369076816 Long EC CORP US N 1 N N N Helix Acquisition Corp N/A Helix Acquisition Corp 000000000 445.00000000 NS USD 4570.15000000 0.075773885122 Long EC CORP KY N 1 N N N Teladoc Health Inc 549300I2PVFBC9MFAC61 Teladoc Health Inc 87918A105 174.00000000 NS USD 34184.04000000 0.566777353038 Long EC CORP US N 1 N N N Gerresheimer AG 5299006GD4UWSYZOKC28 Gerresheimer AG 000000000 366.00000000 NS 36792.70000000 0.610029391410 Long EC CORP DE N 1 N N N eHealth Inc 5299003O8Y5OKXUZQ421 eHealth Inc 28238P109 438.00000000 NS USD 29394.18000000 0.487360637746 Long EC CORP US N 1 N N N Deciphera Pharmaceuticals Inc 529900QR4WAPYY0CBF25 Deciphera Pharmaceuticals Inc 24344T101 192.00000000 NS USD 11149.44000000 0.184859662317 Long EC CORP US N 1 N N N BioMarin Pharmaceutical Inc NSLL8ITTRR0J5HEMR848 BioMarin Pharmaceutical Inc 09061G101 474.00000000 NS USD 35279.82000000 0.584945576803 Long EC CORP US N 1 N N N Galapagos NV 549300QKJ78IY0IOV655 Galapagos NV 36315X101 27.00000000 NS USD 3144.96000000 0.052143986030 Long EC CORP BE N 1 N N N Avidity Biosciences Inc N/A Avidity Biosciences Inc 05370A108 864.00000000 NS USD 21366.72000000 0.354263949045 Long EC CORP US N 1 N N N MyoKardia Inc 549300OLNNNZ1NI9UY54 MyoKardia Inc 62857M105 90.00000000 NS USD 20117.70000000 0.333554979318 Long EC CORP US N 1 N N N Addus HomeCare Corp 52990090ZT33AKPDBX62 Addus HomeCare Corp 006739106 102.00000000 NS USD 9952.14000000 0.165008219223 Long EC CORP US N 1 N N N Amplifon SpA ZYXJDNVM2JI3VBM8G556 Amplifon SpA 000000000 1518.00000000 NS 55186.82000000 0.915007113326 Long EC CORP IT N 1 N N N Praxis Precision Medicines Inc N/A Praxis Precision Medicines Inc 74006W108 1002.00000000 NS USD 35070.00000000 0.581466724561 Long EC CORP US N 1 N N N Global Blood Therapeutics Inc 549300U4G0QKK99GRT15 Global Blood Therapeutics Inc 37890U108 192.00000000 NS USD 10152.96000000 0.168337849894 Long EC CORP US N 1 N N N Edwards Lifesciences Corp YA13X31F3V31L8TMPR58 Edwards Lifesciences Corp 28176E108 660.00000000 NS USD 47315.40000000 0.784497595075 Long EC CORP US N 1 N N N Sarepta Therapeutics Inc 549300IKDPIED8J8IG21 Sarepta Therapeutics Inc 803607100 168.00000000 NS USD 22832.88000000 0.378573137892 Long EC CORP US N 1 N N N ChemoCentryx Inc 529900YTTXUSFQTAKY40 ChemoCentryx Inc 16383L106 178.00000000 NS USD 8544.00000000 0.141661012108 Long EC CORP US N 1 N N N ABIOMED Inc 5493001EZN4ZTB4Z5887 ABIOMED Inc 003654100 192.00000000 NS USD 48360.96000000 0.801833162470 Long EC CORP US N 1 N N N Haemonetics Corp 549300ZEL6TXZS6F5F95 Haemonetics Corp 405024100 648.00000000 NS USD 65506.32000000 1.086106225504 Long EC CORP US N 1 N N N Genmab A/S 529900MTJPDPE4MHJ122 Genmab A/S 372303206 1620.00000000 NS USD 54529.20000000 0.904103658880 Long EC CORP DK N 1 N N N Galecto Inc N/A Galecto Inc 36322Q107 1297.00000000 NS USD 19455.00000000 0.322567297585 Long EC CORP US N 1 N N N Atea Pharmaceuticals Inc N/A Atea Pharmaceuticals Inc 04683R106 535.00000000 NS USD 16231.90000000 0.269127736709 Long EC CORP US N 1 N N N LHC Group Inc 5299009NPLWAMRQYZX73 LHC Group Inc 50187A107 582.00000000 NS USD 126032.10000000 2.089634228017 Long EC CORP US N 1 N N N Stoke Therapeutics Inc 549300RD25SS2DIJHJ67 Stoke Therapeutics Inc 86150R107 240.00000000 NS USD 9213.60000000 0.152763097046 Long EC CORP US N 1 N N N Zai Lab Ltd 549300P2UYQ9U5LY1T58 Zai Lab Ltd 98887Q104 456.00000000 NS USD 37414.80000000 0.620343918052 Long EC CORP KY N 1 N N N Encompass Health Corp 549300FVRPM9DRQZRG64 Encompass Health Corp 29261A100 972.00000000 NS USD 59593.32000000 0.988067652869 Long EC CORP US N 1 N N N Mersana Therapeutics Inc 529900VWD5VDZ7PVOS22 Mersana Therapeutics Inc 59045L106 3666.00000000 NS USD 66061.32000000 1.095308222428 Long EC CORP US N 1 N N N Seagen Inc N/A Seagen Inc 81181C104 1170.00000000 NS USD 195156.00000000 3.235720561689 Long EC CORP US N 1 N N N Eucrates Biomedical Acquisition Corp N/A Eucrates Biomedical Acquisition Corp 000000000 1857.00000000 NS USD 18570.00000000 0.307893843031 Long EC CORP VG N 1 N N N Genmab A/S 529900MTJPDPE4MHJ122 Genmab A/S 000000000 510.00000000 NS 169881.64000000 2.816667259021 Long EC CORP DK N 1 N N N Lonza Group AG 549300EFW4H2TCZ71055 Lonza Group AG 000000000 84.00000000 NS 50882.99000000 0.843648860312 Long EC CORP CH N 1 N N N Amicus Therapeutics Inc 549300MRD1SMUTNBPQ53 Amicus Therapeutics Inc 03152W109 1044.00000000 NS USD 18614.52000000 0.308631992405 Long EC CORP US N 1 N N N Insulet Corp 549300TZTYD2PYN92D43 Insulet Corp 45784P101 336.00000000 NS USD 74676.00000000 1.238141121280 Long EC CORP US N 1 N N N Amedisys Inc 5299001RBS9GK9STN379 Amedisys Inc 023436108 540.00000000 NS USD 139860.00000000 2.318903224896 Long EC CORP US N 1 N N N Arena Pharmaceuticals Inc 529900CVGQMPJ3A3NI85 Arena Pharmaceuticals Inc 040047607 354.00000000 NS USD 30344.88000000 0.503123409774 Long EC CORP US N 1 N N N Nevro Corp 254900SH91I4BOYKUE38 Nevro Corp 64157F103 588.00000000 NS USD 87735.48000000 1.454669580364 Long EC CORP US N 1 N N N ARCUTIS BIOTHERAPEUTICS, INC N/A ARCUTIS BIOTHERAPEUTICS, INC 03969K108 366.00000000 NS USD 6522.12000000 0.108137888611 Long EC CORP US N 1 N N N Avantor Inc N/A Avantor Inc 05352A100 1800.00000000 NS USD 41886.00000000 0.694477194894 Long EC CORP US N 1 N N N Horizon Therapeutics Plc 529900P0GSQ79OOZEV53 Horizon Therapeutics Plc 000000000 396.00000000 NS USD 29672.28000000 0.491971584313 Long EC CORP IE N 1 N N N Envista Holdings Corp 549300BX623VURJZ5269 Envista Holdings Corp 29415F104 918.00000000 NS USD 24253.56000000 0.402128260397 Long EC CORP US N 1 N N N Selectquote Inc 549300BV28BWDIN9SP24 Selectquote Inc 816307300 1308.00000000 NS USD 22523.76000000 0.373447874308 Long EC CORP US N 1 N N N Keros Therapeutics Inc N/A Keros Therapeutics Inc 492327101 498.00000000 NS USD 27688.80000000 0.459085139521 Long EC CORP US N 1 N N N Harmony Biosciences Holdings Inc N/A Harmony Biosciences Holdings Inc 413197104 228.00000000 NS USD 8869.20000000 0.147052884900 Long EC CORP US N 1 N N N Twist Bioscience Corp 549300T23BL59LCOH584 Twist Bioscience Corp 90184D100 570.00000000 NS USD 43684.80000000 0.724301613034 Long EC CORP US N 1 N N N Allakos Inc 549300S6ZD1W6BPMDY37 Allakos Inc 01671P100 524.00000000 NS USD 49848.12000000 0.826490534985 Long EC CORP US N 1 N N N Chemed Corp 54930020031IDJT2IM79 Chemed Corp 16359R103 60.00000000 NS USD 28699.20000000 0.475837747976 Long EC CORP US N 1 N N N FibroGen Inc 549300Q914ULWWY95822 FibroGen Inc 31572Q808 378.00000000 NS USD 14507.64000000 0.240539204787 Long EC CORP US N 1 N N N Humana Inc 529900YLDW34GJAO4J06 Humana Inc 444859102 192.00000000 NS USD 76661.76000000 1.271065368870 Long EC CORP US N 1 N N N Beam Therapeutics Inc N/A Beam Therapeutics Inc 07373V105 396.00000000 NS USD 13531.32000000 0.224351648685 Long EC CORP US N 1 N N N Neurocrine Biosciences Inc 549300FECER0XBN49756 Neurocrine Biosciences Inc 64125C109 408.00000000 NS USD 40257.36000000 0.667474059272 Long EC CORP US N 1 N N N ORIC Pharmaceuticals Inc 54930033FJRNEYBW0L25 ORIC Pharmaceuticals Inc 68622P109 462.00000000 NS USD 9933.00000000 0.164690874681 Long EC CORP US N 1 N N N Forma Therapeutics Holdings Inc N/A Forma Therapeutics Holdings Inc 34633R104 1272.00000000 NS USD 54848.64000000 0.909400029866 Long EC CORP US N 1 N N N IQVIA Holdings Inc 549300W3R20NM4KQPH86 IQVIA Holdings Inc 46266C105 342.00000000 NS USD 52664.58000000 0.873187933646 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 648.00000000 NS USD 79684.56000000 1.321183920766 Long EC CORP US N 1 N N N STERIS PLC N/A STERIS PLC 000000000 324.00000000 NS USD 57409.56000000 0.951860530701 Long EC CORP IE N 1 N N N United Therapeutics Corp 5299005C4HZL4UWROC14 United Therapeutics Corp 91307C102 138.00000000 NS USD 18523.74000000 0.307126844152 Long EC CORP US N 1 N N N Eidos Therapeutics Inc 549300VGYGU07QRG6271 Eidos Therapeutics Inc 28249H104 282.00000000 NS USD 19999.44000000 0.331594207865 Long EC CORP US N 1 N N N Acceleron Pharma Inc 529900TQRID2UY164805 Acceleron Pharma Inc 00434H108 738.00000000 NS USD 77180.04000000 1.279658541781 Long EC CORP US N 1 N N N Royalty Pharma PLC 549300FGFN7VOK8BZR03 Royalty Pharma PLC 000000000 336.00000000 NS USD 12331.20000000 0.204453449498 Long EC CORP GB N 1 N N N Sage Therapeutics Inc 5493000JX4BJS9W6CN35 Sage Therapeutics Inc 78667J108 372.00000000 NS USD 27297.36000000 0.452594995961 Long EC CORP US N 1 N N N Tandem Diabetes Care Inc 549300JEPFOD0K4D3I05 Tandem Diabetes Care Inc 875372203 600.00000000 NS USD 65400.00000000 1.084343421337 Long EC CORP US N 1 N N N Dicerna Pharmaceuticals Inc 549300CTZMJMPH28WN39 Dicerna Pharmaceuticals Inc 253031108 942.00000000 NS USD 19772.58000000 0.327832829447 Long EC CORP US N 1 N N N Prothena Corp PLC 5299009ZXQ8NIIJ8OL30 Prothena Corp PLC 000000000 852.00000000 NS USD 9295.32000000 0.154118028917 Long EC CORP IE N 1 N N N ResMed Inc 529900T3QE5253CCXF22 ResMed Inc 761152107 414.00000000 NS USD 79463.16000000 1.317513070101 Long EC CORP US N 1 N N N Penumbra Inc 549300RGE06P3ECANU72 Penumbra Inc 70975L107 264.00000000 NS USD 68911.92000000 1.142571668252 Long EC CORP US N 1 N N N Blueprint Medicines Corp 5299004CC60O9T5HVM83 Blueprint Medicines Corp 09627Y109 180.00000000 NS USD 18410.40000000 0.305247647158 Long EC CORP US N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 Regeneron Pharmaceuticals Inc 75886F107 162.00000000 NS USD 88056.72000000 1.459995795665 Long EC CORP US N 1 N N N CareDx Inc 549300NQOFKL9NON0U06 CareDx Inc 14167L103 534.00000000 NS USD 26192.70000000 0.434279540245 Long EC CORP US N 1 N N N Wuxi Biologics Cayman Inc 5493001TD2TH6VDTJU11 Wuxi Biologics Cayman Inc 000000000 3500.00000000 NS 97758.18000000 1.620847696710 Long EC CORP KY N 1 N N N Eargo Inc N/A Eargo Inc 270087109 400.00000000 NS USD 13860.00000000 0.229801220485 Long EC CORP US N 1 N N N Krystal Biotech Inc 549300YONUY68210OE41 Krystal Biotech Inc 501147102 384.00000000 NS USD 16508.16000000 0.273708175755 Long EC CORP US N 1 N N N Masimo Corp 549300Q4A8JK0PIYCU29 Masimo Corp 574795100 558.00000000 NS USD 124891.56000000 2.070723875635 Long EC CORP US N 1 N N N Apellis Pharmaceuticals Inc 254900HS0ZFRXXSB9D42 Apellis Pharmaceuticals Inc 03753U106 402.00000000 NS USD 12823.80000000 0.212620843525 Long EC CORP US N 1 N N N Nkarta Inc N/A Nkarta Inc 65487U108 990.00000000 NS USD 28422.90000000 0.471256645723 Long EC CORP US N 1 N N N Baxter International Inc J5OIVXX3P24RJRW5CK77 Baxter International Inc 071813109 1464.00000000 NS USD 113562.48000000 1.882885750745 Long EC CORP US N 1 N N N WuXi AppTec Co Ltd 254900OEPQLZSPLN9175 WuXi AppTec Co Ltd 000000000 6000.00000000 NS 95553.11000000 1.584287251021 Long EC CORP CN N 1 N N N Eisai Co Ltd 353800HDEE0ZYEX4QV91 Eisai Co Ltd 000000000 200.00000000 NS 15475.42000000 0.256585166199 Long EC CORP JP N 1 N N N Shenzhen Mindray Bio-Medical Electronics Co Ltd N/A Shenzhen Mindray Bio-Medical Electronics Co Ltd 000000000 900.00000000 NS 51987.31000000 0.861958678769 Long EC CORP CN N 1 N N N Merck KGaA 529900OAREIS0MOPTW25 Merck KGaA 000000000 468.00000000 NS 69315.77000000 1.149267571780 Long EC CORP DE N 1 N N N Coloplast A/S 529900NN7SOJ5QG82X67 Coloplast A/S 000000000 48.00000000 NS 7005.36000000 0.116150092203 Long EC CORP DK N 1 N N N Sonova Holding AG 5299004A0QNX7FBNHS61 Sonova Holding AG 000000000 150.00000000 NS 35595.44000000 0.590178611522 Long EC CORP CH N 1 N N N UCB SA 2138008J191VLSGY5A09 UCB SA 000000000 918.00000000 NS 90572.41000000 1.501706375201 Long EC CORP BE N 1 N N N Karyopharm Therapeutics Inc 549300J1VANRCNTYST87 Karyopharm Therapeutics Inc 48576U106 954.00000000 NS USD 14138.28000000 0.234415151483 Long EC CORP US N 1 N N N Fate Therapeutics Inc 549300L14Q4UHOODLA90 Fate Therapeutics Inc 31189P102 264.00000000 NS USD 11721.60000000 0.194346175038 Long EC CORP US N 1 N N N Relmada Therapeutics Inc 549300217EASRZ9JSF81 Relmada Therapeutics Inc 75955J402 618.00000000 NS USD 19114.74000000 0.316925727363 Long EC CORP US N 1 N N N Retrophin Inc N/A Retrophin Inc 761299106 924.00000000 NS USD 18701.76000000 0.310078446841 Long EC CORP US N 1 N N N Grifols SA 959800HSSNXWRKBK4N60 Grifols SA 000000000 1650.00000000 NS 44571.22000000 0.738998611436 Long EC CORP ES N 1 N N N Applied Molecular Transport Inc N/A Applied Molecular Transport Inc 03824M109 390.00000000 NS USD 11462.10000000 0.190043619720 Long EC CORP US N 1 N N N GoodRx Holdings Inc N/A GoodRx Holdings Inc 38246G108 162.00000000 NS USD 7839.18000000 0.129974973420 Long EC CORP US N 1 N N N GN Store Nord A/S 5493008U3H3W0NKPFL10 GN Store Nord A/S 000000000 1482.00000000 NS 106591.68000000 1.767308669377 Long EC CORP DK N 1 N N N PMV Pharmaceuticals Inc N/A PMV Pharmaceuticals Inc 69353Y103 1134.00000000 NS USD 39746.70000000 0.659007227291 Long EC CORP US N 1 N N N Hill-Rom Holdings Inc JLZ01A0E2071OH26RE45 Hill-Rom Holdings Inc 431475102 342.00000000 NS USD 31145.94000000 0.516405124470 Long EC CORP US N 1 N N N Pulmonx Corp 549300WZMFR0ZK7RJY40 Pulmonx Corp 745848101 229.00000000 NS USD 9631.74000000 0.159695931269 Long EC CORP US N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 174.00000000 NS USD 116071.92000000 1.924492704189 Long EC CORP US N 1 N N N Livongo Health Inc 54930061HKCVF1H2O156 Livongo Health Inc 539183103 480.00000000 NS USD 67089.60000000 1.112357284405 Long EC CORP US N 1 N N N Alexion Pharmaceuticals Inc M1YXUUZR0EIMU8T0EM75 Alexion Pharmaceuticals Inc 015351109 396.00000000 NS USD 45595.44000000 0.755980357904 Long EC CORP US N 1 N N N PTC Therapeutics Inc 549300UJLWOIWFDGB318 PTC Therapeutics Inc 69366J200 510.00000000 NS USD 26616.90000000 0.441312850327 Long EC CORP US N 1 N N N Berkeley Lights Inc 549300LTLRE4N65CD358 Berkeley Lights Inc 084310101 798.00000000 NS USD 57910.86000000 0.960172172247 Long EC CORP US N 1 N N N Intellia Therapeutics Inc 5493002T5BCPE5DZC723 Intellia Therapeutics Inc 45826J105 342.00000000 NS USD 8187.48000000 0.135749848246 Long EC CORP US N 1 N N N Iovance Biotherapeutics Inc 549300220Z2GHH33XL82 Iovance Biotherapeutics Inc 462260100 1008.00000000 NS USD 35965.44000000 0.596313276139 Long EC CORP US N 1 N N N Nektar Therapeutics 5299005I24806IOIYE03 Nektar Therapeutics 640268108 834.00000000 NS USD 13210.56000000 0.219033391868 Long EC CORP US N 1 N N N Jinxin Fertility Group Ltd 2549000NTC85I8X21O47 Jinxin Fertility Group Ltd 000000000 48000.00000000 NS 58182.94000000 0.964683306162 Long EC CORP KY N 1 N N N Annexon Inc N/A Annexon Inc 03589W102 432.00000000 NS USD 8989.92000000 0.149054443583 Long EC CORP US N 1 N N N 2020-12-01 BlackRock ETF Trust Ann Frechette Ann Frechette Assistant Treasurer XXXX NPORT-EX 2 NPORT_2773690793169507.htm BlackRock Future Health ETF

Schedule of Investments  (unaudited)

October 31, 2020

  

BlackRock Future Health ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Biotechnology — 37.5%

 

Acceleron Pharma Inc.(a)

    738     $ 77,180  

Agios Pharmaceuticals Inc.(a)

    1,038       41,593  

Akeso Inc.(a)(b)

    6,000       18,801  

Akouos Inc.(a)

    655       12,713  

Alexion Pharmaceuticals Inc.(a)

    396       45,595  

Allakos Inc.(a)

    524       49,848  

Alnylam Pharmaceuticals Inc.(a)

    648       79,685  

ALX Oncology Holdings Inc.(a)

    672       26,551  

Amicus Therapeutics Inc.(a)

    1,044       18,614  

Annexon Inc.(a)

    432       8,990  

Apellis Pharmaceuticals Inc.(a)

    402       12,824  

Applied Molecular Transport Inc.(a)

    390       11,462  

Arcutis Biotherapeutics Inc.(a)

    366       6,522  

Arena Pharmaceuticals Inc.(a)

    354       30,345  

Argenx SE, ADR(a)

    282       69,973  

Arrowhead Pharmaceuticals Inc.(a)

    198       11,345  

Avidity Biosciences Inc.(a)

    864       21,367  

Beam Therapeutics Inc.(a)

    396       13,531  

Biohaven Pharmaceutical Holding Co. Ltd.(a)

    205       15,879  

BioMarin Pharmaceutical Inc.(a)

    474       35,280  

Blueprint Medicines Corp.(a)

    180       18,410  

C4 Therapeutics Inc.(a)

    797       19,726  

CareDx Inc.(a)

    534       26,193  

ChemoCentryx Inc.(a)

    178       8,544  

Cytokinetics Inc.(a)

    604       9,283  

Deciphera Pharmaceuticals Inc.(a)

    192       11,149  

Dicerna Pharmaceuticals Inc.(a)

    942       19,773  

Eidos Therapeutics Inc.(a)

    282       19,999  

Fate Therapeutics Inc.(a)

    264       11,722  

FibroGen Inc.(a)

    378       14,508  

Forma Therapeutics Holdings Inc.(a)

    1,272       54,849  

Galecto Inc.(a)

    1,297       19,455  

Genetron Holdings Ltd.(a)

    2,280       23,028  

Genmab A/S(a)

    510       169,882  

Genmab A/S, ADR(a)

    1,620       54,529  

Global Blood Therapeutics Inc.(a)

    192       10,153  

Grifols SA

    1,650       44,571  

Immunovant Inc.(a)

    600       26,172  

Intellia Therapeutics Inc.(a)

    342       8,187  

Iovance Biotherapeutics Inc.(a)

    1,008       35,965  

Kadmon Holdings Inc.(a)

    3,420       11,628  

Karyopharm Therapeutics Inc.(a)

    954       14,138  

Keros Therapeutics Inc.(a)

    498       27,689  

Kodiak Sciences Inc.(a)

    420       38,140  

Krystal Biotech Inc.(a)

    384       16,508  

Kymera Therapeutics Inc.(a)

    636       22,890  

Mersana Therapeutics Inc.(a)

    3,666       66,061  

Mirati Therapeutics Inc.(a)

    213       46,251  

Neurocrine Biosciences Inc.(a)

    408       40,257  

Nkarta Inc.(a)

    990       28,423  

ORIC Pharmaceuticals Inc.(a)

    462       9,933  

PMV Pharmaceuticals Inc.(a)

    1,134       39,747  

Praxis Precision Medicines Inc.(a)

    1,002       35,070  

Prothena Corp. PLC(a)

    852       9,295  

PTC Therapeutics Inc.(a)

    510       26,617  

Rapt Therapeutics Inc.(a)

    444       12,761  

Regeneron Pharmaceuticals Inc.(a)

    162       88,057  

Retrophin Inc.(a)

    924       18,702  
Security   Shares     Value  
Biotechnology (continued)            

Sage Therapeutics Inc.(a)

    372     $ 27,297  

Sarepta Therapeutics Inc.(a)

    168       22,833  

Seagen Inc.(a)

    1,170       195,156  

Seres Therapeutics Inc.(a)

    876       24,432  

Stoke Therapeutics Inc.(a)

    240       9,214  

Taysha Gene Therapies Inc.(a)

    420       8,736  

TCR2 Therapeutics Inc.(a)

    534       10,504  

Twist Bioscience Corp.(a)

    570       43,685  

United Therapeutics Corp.(a)

    138       18,524  

Vertex Pharmaceuticals Inc.(a)

    205       42,714  

Vir Biotechnology Inc.(a)

    312       9,809  

Zai Lab Ltd., ADR(a)

    456       37,415  

Zentalis Pharmaceuticals Inc.(a)

    534       21,141  

Zymeworks Inc.(a)

    594       23,237  
   

 

 

 
      2,261,060  

Diversified Financial Services — 0.4%

 

Eucrates Biomedical Acquisition Corp.(a)

    1,857       18,570  

Helix Acquisition Corp.(a)

    445       4,570  
   

 

 

 
      23,140  

Health Care Equipment & Supplies — 27.7%

 

ABIOMED Inc.(a)

    192       48,361  

Alcon Inc.(a)

    1,830       104,017  

Baxter International Inc.

    1,464       113,563  

Cardiovascular Systems Inc.(a)

    396       14,117  

Coloplast A/S, Class B

    48       7,005  

ConvaTec Group PLC(b)

    10,962       25,612  

Demant A/S(a)

    1,644       51,778  

Eargo Inc.(a)

    400       13,860  

Edwards Lifesciences Corp.(a)

    660       47,315  

Envista Holdings Corp.(a)

    918       24,254  

GN Store Nord A/S

    1,482       106,592  

Haemonetics Corp.(a)

    648       65,506  

Hill-Rom Holdings Inc.

    342       31,146  

Insulet Corp.(a)

    336       74,676  

Intuitive Surgical Inc.(a)

    174       116,072  

Masimo Corp.(a)

    558       124,892  

Nevro Corp.(a)

    588       87,736  

NuVasive Inc.(a)

    324       14,395  

Penumbra Inc.(a)

    264       68,912  

Pulmonx Corp.(a)

    229       9,632  

ResMed Inc.

    414       79,463  

Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Class A

    900       51,987  

Silk Road Medical Inc.(a)

    708       42,905  

Sonova Holding AG, Registered(a)

    150       35,595  

STERIS PLC

    324       57,410  

Straumann Holding AG, Registered

    78       81,357  

Tandem Diabetes Care Inc.(a)

    600       65,400  

Teleflex Inc.

    336       106,925  
   

 

 

 
      1,670,483  

Health Care Providers & Services — 10.0%

 

Addus HomeCare Corp.(a)

    102       9,952  

Amedisys Inc.(a)

    540       139,860  

Amplifon SpA(a)

    1,518       55,187  

Centene Corp.(a)

    846       49,999  

Chemed Corp.

    60       28,699  

Encompass Health Corp.

    972       59,593  

Humana Inc.

    192       76,662  

Jinxin Fertility Group Ltd.(b)

    48,000       58,183  
 

 

 

    

  1


Schedule of Investments  (unaudited) (continued)

October 31, 2020

  

BlackRock Future Health ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Health Care Providers & Services (continued)            

LHC Group Inc.(a)

    582     $ 126,032  
   

 

 

 
      604,167  
Health Care Technology — 2.5%            

American Well Corp., Class A(a)

    1,566       40,418  

GoodRx Holdings Inc., Class A(a)

    162       7,839  

Livongo Health Inc.(a)(c)

    480       67,090  

Teladoc Health Inc.(a)

    174       34,184  
   

 

 

 
      149,531  
Insurance — 0.9%            

eHealth Inc.(a)

    438       29,394  

Selectquote Inc.(a)

    1,308       22,524  
   

 

 

 
      51,918  
Life Sciences Tools & Services — 10.8%            

10X Genomics Inc., Class A(a)

    114       15,607  

Avantor Inc.(a)

    1,800       41,886  

Berkeley Lights Inc.(a)

    798       57,911  

Charles River Laboratories International Inc.(a)

    216       49,183  

Gerresheimer AG

    366       36,793  

Illumina Inc.(a)

    84       24,587  

IQVIA Holdings Inc.(a)

    342       52,665  

Lonza Group AG, Registered

    84       50,883  

PPD Inc.(a)

    3,996       131,388  

WuXi AppTec Co. Ltd., Class H(b)

    6,000       95,553  

Wuxi Biologics Cayman Inc.(a)(b)

    3,500       97,758  
   

 

 

 
      654,214  
Pharmaceuticals — 7.7%            

Astellas Pharma Inc.

    2,400       32,944  

Atea Pharmaceuticals Inc.

    535       16,232  

Chugai Pharmaceutical Co. Ltd.

    700       26,925  

Eisai Co. Ltd.

    200       15,475  

Hansoh Pharmaceutical Group Co. Ltd.(a)(b)

    24,000       106,927  

Harmony Biosciences Holdings Inc.(a)

    228       8,869  
Security   Shares     Value  
Pharmaceuticals (continued)            

Horizon Therapeutics PLC(a)

    396     $ 29,672  

Merck KGaA

    468       69,316  

MyoKardia Inc.(a)

    90       20,118  

Nektar Therapeutics(a)

    834       13,211  

Relmada Therapeutics Inc.(a)

    618       19,115  

Royalty Pharma PLC, Class A

    336       12,331  

UCB SA

    918       90,572  
   

 

 

 
      461,707  
   

 

 

 

Total Common Stocks — 97.5%
(Cost: $5,880,996)

      5,876,220  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 2.3%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.04%(d)(e)

    140,000       140,000  
   

 

 

 

Total Short-Term Investments — 2.3%
(Cost: $140,000)

      140,000  
   

 

 

 

Total Investments in Securities — 99.8%
(Cost: $6,020,996)

      6,016,220  

Other Assets, Less Liabilities — 0.2%

      14,906  
   

 

 

 

Net Assets — 100.0%

    $ 6,031,126  
   

 

 

 

 

(a) 

Non-income producing security.

(b)

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(c) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)

Affiliate of the Fund.

(e) 

Annualized 7-day yield as of period-end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended October 31, 2020 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   

Value at

09/29/20(a)

    

Purchases

at Cost

     Proceeds
from Sales
     Net Realized
Gain (Loss)
    

Change in

Unrealized

Appreciation

(Depreciation)

    

Value at

10/31/20

    

Shares

Held at

10/31/20

     Income     

Capital

Gain

Distributions

from

Underlying

Funds

 

BlackRock Cash Funds: Treasury, SL Agency Shares

   $      $ 140,000 (b)     $      $      $      $ 140,000        140,000      $ 6      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

The Fund commenced operations on September 29, 2020.

 
  (b) 

Represents net amount purchased (sold).

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to a recently published shareholder report. Shareholder reports are available on the Fund’s website at iShares.com and on the U.S. Securities and Exchange Commission website at sec.gov.

 

 

2  

    


Schedule of Investments  (unaudited) (continued)

October 31, 2020

   BlackRock Future Health ETF

 

Fair Value Measurements (continued)

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of October 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 5,809,130        $        $  67,090        $ 5,876,220  

Money Market Funds

     140,000                            140,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 5,949,130        $        $  67,090        $ 6,016,220  
  

 

 

      

 

 

      

 

 

      

 

 

 

The following table includes a rollforward for the period ended October 31, 2020 of investments whose values are classified as Level 3 as of the beginning or end of the period.

 

      Common
Stocks
 

Balance at beginning of period(a)

   $  

Realized gain (loss) and change in unrealized appreciation/depreciation

     506  

Purchases

     66,584  

Sales

      

Transfers in

      

Transfers out

      
  

 

 

 

Balance at end of period

   $ 67,090  
  

 

 

 

Net change in unrealized appreciation/depreciation on investments still held at end of period

   $ 506  
  

 

 

 

 

  (a)

The Fund commenced operations on September 29, 2020.

 

The Fund’s investments that are categorized as Level 3 were valued utilizing a single broker quote without adjustment. Such valuations are based on unobservable inputs. A significant change in third party information could result in a significantly lower or higher value of such Level 3 investments.

Portfolio Abbreviations - Equity

ADR American Depositary Receipt

 

 

    

  3